Clinical trials
Completed Osteoporosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,025 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 21 |
| 2001 | 28 |
| 2002 | 24 |
| 2003 | 44 |
| 2004 | 50 |
| 2005 | 41 |
| 2006 | 69 |
| 2007 | 61 |
| 2008 | 56 |
| 2009 | 57 |
| 2010 | 46 |
| 2011 | 42 |
| 2012 | 55 |
| 2013 | 41 |
| 2014 | 38 |
| 2015 | 41 |
| 2016 | 27 |
| 2017 | 28 |
| 2018 | 31 |
| 2019 | 37 |
| 2020 | 25 |
| 2021 | 22 |
| 2022 | 28 |
| 2023 | 21 |
| 2024 | 19 |
| 2025 | 11 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,025 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 30 |
| Eli Lilly and Company | 23 |
| Novartis Pharmaceuticals | 19 |
| GlaxoSmithKline | 18 |
| Merck Sharp & Dohme LLC | 17 |
| University of Aarhus | 13 |
| Massachusetts General Hospital | 12 |
| National Taiwan University Hospital | 11 |
| University of Alabama at Birmingham | 11 |
| Novartis | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis | 1,025 |
| Bone Diseases, Metabolic | 196 |
| Osteoporosis, Postmenopausal | 89 |
| Fractures, Bone | 80 |
| Breast Neoplasms | 33 |
| Sarcopenia | 32 |
| Spinal Fractures | 31 |
| Diabetes Mellitus | 30 |
| Cardiovascular Diseases | 26 |
| Osteoporotic Fractures | 26 |
Trials
Showing 1 to 25 of 1,025. Each trial links to its page on Pharma Observatory.
925 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.